微生物与感染
微生物與感染
미생물여감염
JOURNAL OF MICROBES AND INFECTION
2013年
3期
174-180
,共7页
李慧一%曹风雅%胡澜也%佘凯芩%崔泽林
李慧一%曹風雅%鬍瀾也%佘凱芩%崔澤林
리혜일%조풍아%호란야%사개금%최택림
金黄色葡萄球菌%耐药性%噬菌体%裂解酶%治疗
金黃色葡萄毬菌%耐藥性%噬菌體%裂解酶%治療
금황색포도구균%내약성%서균체%렬해매%치료
Staphylococcus aureus%Drug resistance%Bacteriophage%Lysin%Therapy
近70年来,由于抗生素的广泛使用,耐药金黄色葡萄球菌不断出现。美国1999~2005年因感染耐甲氧西林金黄色葡萄球菌(MRSA)而入院的患者增加1倍多,其中诊断为败血症的患者增加81.2%。因此,寻找控制耐药菌的新对策十分迫切。目前有望替代抗生素的控菌手段有抗菌肽、噬菌体等。其中,噬菌体的发现早于抗生素,后因抗生素的普及而被忽视。如今,耐药菌株的流行使噬菌体治疗再次受到关注。本文就应用噬菌体及其裂解酶控制金黄色葡萄球菌的研究进展进行综述。
近70年來,由于抗生素的廣汎使用,耐藥金黃色葡萄毬菌不斷齣現。美國1999~2005年因感染耐甲氧西林金黃色葡萄毬菌(MRSA)而入院的患者增加1倍多,其中診斷為敗血癥的患者增加81.2%。因此,尋找控製耐藥菌的新對策十分迫切。目前有望替代抗生素的控菌手段有抗菌肽、噬菌體等。其中,噬菌體的髮現早于抗生素,後因抗生素的普及而被忽視。如今,耐藥菌株的流行使噬菌體治療再次受到關註。本文就應用噬菌體及其裂解酶控製金黃色葡萄毬菌的研究進展進行綜述。
근70년래,유우항생소적엄범사용,내약금황색포도구균불단출현。미국1999~2005년인감염내갑양서림금황색포도구균(MRSA)이입원적환자증가1배다,기중진단위패혈증적환자증가81.2%。인차,심조공제내약균적신대책십분박절。목전유망체대항생소적공균수단유항균태、서균체등。기중,서균체적발현조우항생소,후인항생소적보급이피홀시。여금,내약균주적류행사서균체치료재차수도관주。본문취응용서균체급기렬해매공제금황색포도구균적연구진전진행종술。
In recent years , the wide use of antibiotics leads to the increase in drug-resistant bacteria . In America ,methicillin-resistant Staphylococcus aureus (MRSA )-related hospitalizations were doubled from 1999 to 2005 ,and MRSA-related hospitalizations with confirmed septicemia increased 81 .2% .Therefore ,it is urgent to seek novel countermeasures ,such as antibacterial peptides and bacteriophages to control drug-resistant bacteria .Despite the bacteriophage being discovered earlier than antibiotics ,it was ignored owing to popularity of antibiotics .But now bacteriophages have come back into view as a result of increase in drug-resistant bacteria . Here , the research progress on bacteriophage and lysin in control of Staphylococcus aureus is reviewed .